Xenon Pharmaceuticals Inc.XENENASDAQ
LOADING
|||
Year-over-year net income growth rate
| Period | Value |
|---|---|
| Q3 2025 | -7.31% |
| Q2 2025 | -30.22% |
| Q1 2025 | 0.97% |
| Q4 2024 | -4.61% |
| Q3 2024 | -8.40% |
| Q2 2024 | -20.85% |
| Q1 2024 | -7.13% |
| Q4 2023 | 7.67% |
| Q3 2023 | -2.11% |
| Q2 2023 | -13.74% |
| Q1 2023 | -11.58% |
| Q4 2022 | -0.66% |
| Q3 2022 | -19.23% |
| Q2 2022 | -58.40% |
| Q1 2022 | 23.06% |
| Q4 2021 | -65.52% |
| Q3 2021 | 30.14% |
| Q2 2021 | -40.25% |
| Q1 2021 | -27.92% |
| Q4 2020 | -39.16% |
| Q3 2020 | -4960.00% |
| Q2 2020 | 97.66% |
| Q1 2020 | 34.21% |
| Q4 2019 | -28.24% |
| Q3 2019 | 11.35% |
| Q2 2019 | 11.76% |
| Q1 2019 | -32.52% |
| Q4 2018 | 40.50% |
| Q3 2018 | -84.37% |
| Q2 2018 | -107.75% |
| Q1 2018 | 53.44% |
| Q4 2017 | -4.17% |
| Q3 2017 | -4.91% |
| Q2 2017 | 1.82% |
| Q1 2017 | -25.20% |
| Q4 2016 | 22.17% |
| Q3 2016 | -28.22% |
| Q2 2016 | -84.37% |
| Q1 2016 | 17.12% |
| Q4 2015 | -2.87% |